MOAB VX15/2503

MOAB VX15/2503 Uses, Dosage, Side Effects, Food Interaction and all others data.

MOAB VX15/2503 is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma).

Trade Name MOAB VX15/2503
Generic Pepinemab
Pepinemab Other Names MOAB VX15/2503, Pepinemab, VX15/2503
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
MOAB VX15/2503
MOAB VX15/2503

Innovators Monograph

You find simplified version here MOAB VX15/2503


*** Taking medicines without doctor's advice can cause long-term problems.
Share